| 1. | Short - term clinical observation of low - dose sirolimus in living relative kidney transplantation from elderly donor
接受老龄亲属活体供肾移植者采用小剂量西罗莫司的近期临床观察 |
| 2. | In all 4 patients , sirolimus - induced pneumonitis resoled following cessation of therapy but took weeks to months for complete recoery
发生西罗莫司诱发性肺炎的4名病人均停止使用西罗莫司，但病人在数周到数月之后才完全恢复。 |
| 3. | A novel , simple and cost effective assay for monitoring blood levels of rapamycin ( sirolimus ) and rapamycin analogues was developed
我们开发了一项用于检测血液中雷帕霉素（西罗莫司）和雷帕霉素类似物浓度的简便、经济节省的新型分析方法。 |
| 4. | All cases of sirolimus - induced pneumonitis were recorded and a retrospectie reiew of the case notes of such patients was undertaken for the purpose of this analysis
所有的患西罗莫司诱发性肺炎的病人资料均进行了记录，我们回顾性分析了这些病人的资料数据。 |
| 5. | Therefore , newer immunosuppressie agents such as mycophenolate mofetil and sirolimus ( rapa ) hae raised the possibility of withdrawing or aoiding cnis altogether
因此，新的免疫抑制剂如：麦考酚酸吗乙酯和西罗莫司（雷帕霉素）的使用使cni撤退或避免其使用的可行性上升。 |
| 6. | Therefore , newer immunosuppressive agents such as mycophenolate mofetil and sirolimus ( rapa ) have raised the possibility of withdrawing or avoiding cnis altogether
因此，新的免疫抑制剂如：麦考酚酸吗乙酯和西罗莫司（雷帕霉素）的使用使cni撤退或避免其使用的可行性上升。 |
| 7. | Mortality was similar with bare - metal , sirolimus - eluting , and paclitaxel - eluting stents , but sirolimus stents were superior to the other types in terms of mi and revascularization
裸支架，西罗莫司药物支架和紫杉醇药物支架析死亡率相似，但西罗莫司支架在心梗和血运重建方面要优于其它类型。 |
| 8. | We report our experience , the largest to date , of sirolimus - induced pneumonitis following lt . between 1999 and 2006 , 186 lier transplant patients receied sirolimus - based immunosuppression , after initial therapy with calcineurin inhibitors ( cnis )
我们报道了至今为止在肝移植术后西罗莫司诱发性肺炎方面病例数最多的经验. 1999年至2006年, 186例患者开始给予钙调抑制剂,后接受基于西罗莫司的免疫抑制治疗 |
| 9. | Calcineurin inhibitor minimization and addition of mycophenolate mofetil ( mmf ) or sirolimus have shown variable improvements in renal function , though suboptimal efficacy and safety with the currently proposed regimes have limited their application
钙调磷酸酶抑制剂最小化以及附加麦考酚酸莫酯( mmf )或西罗莫司，已经展现出不定的改善肾功能的作用，虽然欠佳的疗效和安全性以及当前提出的管理体制限制了它们的应用。 |
| 10. | Sirolimus - induced pneumonitis has emerged as a potentially serious complication in renal transplantation but only single case reports of this condition hae been described after lier transplantation ( lt ) , where experience with sirolimus is relatiely limited
西罗莫司诱发性肺炎一直是肾移植后一个潜在的严重并发症，但肝移植后西罗莫司诱发性肺炎方面的资料却寥寥无几，只有一篇个案报道曾进行过描述，这可能是由于在肝移植中对西罗莫司的使用经验尚较为缺乏。 |
